FP7-PEOPLE-2011-CIG
FP7-PEOPLE-2011-CIG
Programme: FP7
469 projects · €43,983,333 total EU contribution (project-level) · 260 participating organizations · 32 countries with participants
Total EU funding
Sum of EC max contribution fields for distinct projects in this topic.
€43,983,333
Countries active
Participant organizations by country (headquarters in CORDIS).
- Spain (47)
- Germany (31)
- UK (20)
- France (19)
- TR (19)
- Italy (17)
- Netherlands (16)
- EL (10)
- IL (10)
- AT (7)
- BE (7)
- SE (6)
- CH (5)
- CZ (5)
- FI (5)
- HU (5)
- PT (5)
- IE (4)
- PL (4)
- DK (3)
- BG (2)
- RO (2)
- CY (1)
- HR (1)
- IS (1)
- LT (1)
- LU (1)
- MT (1)
- NO (1)
- RS (1)
- SI (1)
- SK (1)
Open calls
From the EU Funding & Tenders Portal, linked to this topic code when it matches the call identifier. Sync via yarn etl:funding.
No open or forthcoming calls linked to this topic in the database yet.
Top organizations
By number of distinct projects in this topic.
- CSIC22 projects · ES
- CNRS18 projects · FR
- BGU13 projects · IL
- TECHNION - ISRAEL INSTITUTE OF TECHNOLOGY11 projects · IL
- TAU11 projects · IL
- INSERM8 projects · FR
- UNIVLEEDS7 projects · UK
- BOGAZICI UNIVERSITESI6 projects · TR
- UCPH6 projects · DK
- IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE5 projects · UK
- REICHMAN UNIVERSITY5 projects · IL
- SABANCI UNIVERSITY5 projects · TR
Projects
Page 18 of 47
| Project | Programme | EU contribution | Total cost | |
|---|---|---|---|---|
Developing the Substance Use Normalization Theory (SUNT):Explaining Adolescent Substance Use in Contemporary Society SUNT · 293591 | FP7 | €100,000 | €100,000 | Details |
The Moral Compass: How Moral Judgment Guides Political Attitudes MORALCOMPASS · 293769 | FP7 | €100,000 | €100,000 | Details |
Genetic Control of Gene Expression in Cancer Risk GenCaR · 303745 | FP7 | €100,000 | €100,000 | Details |
Molecular recognition of bacterial cell wall peptidoglycans and related molecules by innate immune receptors PGN-INNATE · 303917 | FP7 | €100,000 | €100,000 | Details |
NonLinear Optics for Photovoltaics NLO FOR PV · 303921 | FP7 | €100,000 | €100,000 | Details |
Phase I trial in recurrent high-grade glioma: High-dose vorinostat with concurrent hypofractionated radiation therapy RECURRENT GLIOMA TX · 303795 | FP7 | €100,000 | €100,000 | Details |
Synthesis and characterization of NANOstructured materials with LumInescent properties for diaGnostic and tHerapeuTic applications NANOLIGHT · 294094 | FP7 | €75,000 | €75,000 | Details |
Regulation of stage conversion in the malaria parasite: molecular insights for novel vaccine strategies STACOMAL · 304081 | FP7 | €100,000 | €100,000 | Details |
Modulating EB protein interactions through small molecules EB-SxIP · 293831 | FP7 | €75,000 | €75,000 | Details |
The role of DREAM in synaptic dysfunction in Alzheimer's disease DREAM IN AD · 303701 | FP7 | €60,417 | €60,417 | Details |